Physician profile
Michael Marks
NPI 1811043268
$254,318.51
in general payments reported to CMS, 2019-2025
5 companies · $18.38 in 2025
The $18.38 reported for 2025 was less than what a typical Neuroradiology provider received nationally (typical 2025 total: $278).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $250K · 2020: $145 · 2021: $15.01 · 2023: $3,641 · 2024: $56.84 · 2025: $18.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,620 · Food and Beverage: $96.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,620.00 |
| Food and Beverage | $96.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $250,215.73 | 2019 | |
| Genentech, INC. | $3,620.00 | 2023 | Tnkase |
| Microvention, INC. | $386.17 | 2019-2021 | |
| Stryker Corporation | $96.61 | 2023-2025 | Surpass Evolve, Evolve, Target |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Marks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.